B
BioMarin Pharmaceutical Inc. (BMRN)
NMS – Real vaqt narxi. Valyuta: USD
52.88
+0.30 (0.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
52.88
+0.30 (0.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
| Tarkibi | |
|---|---|
| 0.31% | Insayderlar egalik qilgan aksiyalar ulushi |
| 100.02% | Institusional investorlar egalik qilgan aksiyalar ulushi |
| 100.33% | Institusional investorlar egalik qilgan erkin aksiyalar ulushi |
| 781 | Institusional investorlar soni |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| Primecap Management Company | 14.19M | 2026-03-31 | 7.34% | $753.42M |
| Vanguard Capital Management LLC | 8.64M | 2026-03-31 | 4.47% | $458.78M |
| Vanguard Portfolio Management LLC | 8.30M | 2026-03-31 | 4.29% | $440.48M |
| Dimensional Fund Advisors LP | 3.80M | 2026-03-31 | 1.97% | $201.86M |
| Aksiyador | Aksiyalar | Hisobot sanasi | % ulushi | Qiymat |
|---|---|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 9.77M | 2025-12-31 | 5.05% | $518.57M |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 6.37M | 2026-03-31 | 3.30% | $338.15M |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 6.05M | 2025-12-31 | 3.13% | $321.20M |
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | 5.29M | 2025-12-31 | 2.74% | $281.02M |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | 5.21M | 2025-12-31 | 2.70% | $276.78M |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 4.36M | 2025-12-31 | 2.25% | $231.25M |
| CAPITAL WORLD GROWTH & INCOME FUND | 2.58M | 2026-03-31 | 1.33% | $136.75M |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 2.46M | 2025-12-31 | 1.27% | $130.55M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.07M | 2025-12-31 | 1.07% | $109.84M |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.81M | 2026-02-28 | 0.94% | $99.08M |
| Fidelity Contrafund | 1.77M | 2026-03-31 | 0.92% | $94.09M |